2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
547
Squamous Cell Carcinoma of Head and Neck
281
Head and Neck Neoplasms
258
Lung Neoplasms
241
Uterine Cervical Neoplasms
182
Stomach Neoplasms
172
Esophageal Neoplasms
161
Nasopharyngeal Carcinoma
127
Urinary Bladder Neoplasms
117
Neoplasms
116
Esophageal Squamous Cell Carcinoma
116
Small Cell Lung Carcinoma
106
Ovarian Neoplasms
92
Breast Neoplasms
92
Neoplasm Metastasis
91
Cholangiocarcinoma
78
Carcinoma, Squamous Cell
76
Pancreatic Neoplasms
74
Biliary Tract Neoplasms
72
Oropharyngeal Neoplasms
57
Mesothelioma, Malignant
57
Carcinoma
56
Adenocarcinoma Of Esophagus
52
Recurrence
48
Parkinson Disease 4, Autosomal Dominant Lewy Body
47
Carcinoma, Ovarian Epithelial
46
Nasopharyngeal Neoplasms
41
Lymphoma
41
Adenocarcinoma of Lung
41
Triple Negative Breast Neoplasms
39
Interventions
Cyclophosphamide
10
Doxorubicin
9
Vincristine
7
Prednisone
7
Etoposide
6
Brentuximab Vedotin
4
prednylidene
3
etoposide phosphate
3
Bortezomib
3
romidepsin
2
pembrolizumab
2
fludarabine
2
duvelisib
2
deltacortene
2
Vorinostat
2
Prednisolone
2
Ifosfamide
2
tazemetostat
1
pirarubicin
1
fludarabine phosphate
1
cc-486
1
Sensitivity and Specificity
1
Salvia hispanica seed extract
1
Receptors, Chimeric Antigen
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Nivolumab
1
Methylprednisolone
1
Methotrexate
1
Melphalan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enteropathy-Associated T-Cell Lymphoma
×
Cisplatin
×
Clear all
NCT01719835
2018-03-15
CHEMO-T
Royal Marsden NHS Foundation Trust
Phase 2
Unknown
87 enrolled